000 02435 a2200661 4500
005 20250517005500.0
264 0 _c20150316
008 201503s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2013.54.3298
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCainap, Calin
245 0 0 _aLinifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJan 2015
300 _a172-9 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHand-Foot Syndrome
_xetiology
650 0 4 _aHumans
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aIndazoles
_xadministration & dosage
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNiacinamide
_xadministration & dosage
650 0 4 _aOdds Ratio
650 0 4 _aPhenylurea Compounds
_xadministration & dosage
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aReceptor Protein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aRisk Factors
650 0 4 _aSorafenib
650 0 4 _aTreatment Outcome
700 1 _aQin, Shukui
700 1 _aHuang, Wen-Tsung
700 1 _aChung, Ik Joo
700 1 _aPan, Hongming
700 1 _aCheng, Ying
700 1 _aKudo, Masatoshi
700 1 _aKang, Yoon-Koo
700 1 _aChen, Pei-Jer
700 1 _aToh, Han-Chong
700 1 _aGorbunova, Vera
700 1 _aEskens, Ferry A L M
700 1 _aQian, Jiang
700 1 _aMcKee, Mark D
700 1 _aRicker, Justin L
700 1 _aCarlson, Dawn M
700 1 _aEl-Nowiem, Saied
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 33
_gno. 2
_gp. 172-9
856 4 0 _uhttps://doi.org/10.1200/JCO.2013.54.3298
_zAvailable from publisher's website
999 _c24441644
_d24441644